ArticlePDF Available

Abstract and Figures

Growing evidence indicates that the human gut microbiota interacts with xenobiotics, including persistent organic pollutants and foodborne chemicals. The toxicological relevance of the gut microbiota-pollutant interplay is of great concern since chemicals may disrupt gut microbiota functions, with a potential impairment of host homeostasis. Herein we report within batch fermentation systems the impact of food contaminants (polycyclic aromatic hydrocarbons, polychlorobiphenyls, brominated flame retardants, dioxins, pesticides and heterocyclic amines) on the human gut microbiota by metatranscriptome and volatolome i.e. "volatile organic compounds" analyses. Inflammatory host cell response caused by microbial metabolites following the pollutants-gut microbiota interaction, was evaluated on intestinal epithelial TC7 cells. Changes in the volatolome pattern analyzed via solid-phase microextraction coupled to gas chromatography-mass spectrometry mainly resulted in an imbalance in sulfur, phenolic and ester compounds. An increase in microbial gene expression related to lipid metabolism processes as well as the plasma membrane, periplasmic space, protein kinase activity and receptor activity was observed following dioxin, brominated flame retardant and heterocyclic amine exposure. Conversely, all food contaminants tested induced a decreased in microbial transcript levels related to ribosome, translation and nucleic acid binding. Finally, we demonstrated that gut microbiota metabolites resulting from pollutant disturbances may promote the establishment of a pro-inflammatory state in the gut, as stated with the release of cytokine IL-8 by intestinal epithelial cells.
This content is subject to copyright. Terms and conditions apply.
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
Food Chemicals Disrupt Human
Gut Microbiota Activity And Impact
Intestinal Homeostasis As Revealed
By In Vitro Systems
Clémence Defois1, Jérémy Ratel2, Ghislain Garrait1, Sylvain Denis1, Olivier Le Go1,
Jérémie Talvas3,4, Pascale Mosoni1, Erwan Engel2 & Pierre Peyret1
Growing evidence indicates that the human gut microbiota interacts with xenobiotics, including
persistent organic pollutants and foodborne chemicals. The toxicological relevance of the gut
microbiota-pollutant interplay is of great concern since chemicals may disrupt gut microbiota functions,
with a potential impairment of host homeostasis. Herein we report within batch fermentation systems
the impact of food contaminants (polycyclic aromatic hydrocarbons, polychlorobiphenyls, brominated
ame retardants, dioxins, pesticides and heterocyclic amines) on the human gut microbiota by
metatranscriptome and volatolome i.e. “volatile organic compounds” analyses. Inammatory host
cell response caused by microbial metabolites following the pollutants-gut microbiota interaction,
was evaluated on intestinal epithelial TC7 cells. Changes in the volatolome pattern analyzed via solid-
phase microextraction coupled to gas chromatography-mass spectrometry mainly resulted in an
imbalance in sulfur, phenolic and ester compounds. An increase in microbial gene expression related to
lipid metabolism processes as well as the plasma membrane, periplasmic space, protein kinase activity
and receptor activity was observed following dioxin, brominated ame retardant and heterocyclic
amine exposure. Conversely, all food contaminants tested induced a decreased in microbial transcript
levels related to ribosome, translation and nucleic acid binding. Finally, we demonstrated that gut
microbiota metabolites resulting from pollutant disturbances may promote the establishment of a pro-
inammatory state in the gut, as stated with the release of cytokine IL-8 by intestinal epithelial cells.
People are exposed on a daily basis to a variety of environmental pollutants arising from industries, transports,
heating or agriculture. Persistent organic pollutants (POPs), such as polycyclic aromatic hydrocarbons (PAHs),
polychlorobiphenyls (PCBs), brominated ame retardants (BFRs), polychlorinated dibenzo-p-dioxins (PCDDs)
and pesticides, are compounds that cause concern because of their toxicity, persistence in the environment,
capacity to move over very long distances and ability to accumulate in organisms1. Exposure to these pollutants
has been linked to various pathologies, including metabolic2, immune3,4 and reproductive disturbances5 and even
cancers6,7. Heterocyclic amines (HCAs) are foodborne chemicals produced by some cooking practices that are
similar to POPs in terms of structure and toxic properties. HCAs are mutagenic and characterized as possible
human carcinogens8, increasing the risk of the emergence of colorectal cancer9.
Because exposure to POPs and foodborne chemicals occurs mainly through the diet, the host gastrointesti-
nal tract (GIT) and the gut microbiota are likely to be exposed to these compounds. Recent studies have shown
that xenobiotic-microbiota interactions may lead to modications of the gut microbiota composition and func-
tions, which could then impact host homeostasis10,11. In a murine model, Zhang and colleagues have shown that
ve days of orally administered 2,3,7,8-tetrachlorodibenzofuran (TCDF) lead to dramatic modications of the
structure of the mice gut microbiota by reducing the ratio of Firmicutes to Bacteroidetes, accompanied by acti-
vation of the microbial fermentation (elevation of short chain fatty acids in feces and cecal content extracts)12.
Conversely, chronic exposure (26 weeks) of the mouse gut microbiota to 2,3,7,8-tetrachlorodibenzo-p-dioxin
1MEDIS, Université Clermont Auvergne, INRA, Clermont-Ferrand, France. 2UR370 QuaPA, MASS Group, INRA, Saint-
Genès-Champanelle, France. 3UMR 1019, Unité de Nutrition Humaine, Equipe ECREIN, CLARA, Université Clermont
Auvergne, Clermont-Ferrand, France. 4UMR 1019, Unité de Nutrition Humaine, CRNH Auvergne, INRA, Clermont-
Ferrand, France. Correspondence and requests for materials should be addressed to P.P. (email:
Received: 30 January 2018
Accepted: 4 July 2018
Published: xx xx xxxx
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
(TCDD) induced a major increase in the Firmicutes to Bacteroidetes ratio, while the same exposure on a short
time scale (2 days) did not appear to have any signicant eects13. To complement these observations, a recent
study showed an increase of 13 antimicrobial resistance genes and 1 mobile genetic element gene along with
a bloom of Enterobacteriaceae (bacterial groups harboring these genes) within 8 days of TCDD exposure in the
murine gut microbiome14. Finally, acute exposure to a mixture of PCBs or benzo[a]pyrene (B[a]P) induced either
a substantial decrease in the level of Proteobacteria in the mouse gut microbiota or showed no signicant impact
on the human gut microbiota but induced a shi in microbial metabolic activity, respectively15,16.
e gut microbiota may, in return, metabolize chemical compounds, which might deect their therapeu-
tic (drugs) or toxic (environmental and foodborne chemicals) properties toward the host17,18. A previous work
reported that six commonly used host-targeted drugs, induced 328 microbial genes, most of which could be asso-
ciated with drug transport or degradation19. Dichlorodiphenyltrichloroethane (DDT), an organochlorine insec-
ticide, has been found to be metabolized to dichlorodiphenyldichlorophenylethane (DDD) by rat and human
fecal microbiota, although it remains unclear whether this biotransformation corresponds to bioactivation or
detoxication because both DDT and DDD are probable endocrine disruptors in humans20. Finally, the human
gut microbiota has been shown to biotransform B[a]P and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP) into 7-hydroxybenzo[a]pyrene and 7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido[3,2:4,5]
imidazo[1,2-a]pyrimidin-5-ium chloride (PhIP-M1) identied as B[a]P and PhIP derivatives, respectively2123.
Beside metabolomics where all metabolites produced by living organisms are analyzed, volatolomics focuses
on the study of volatile metabolites reducing the complexity of the analysis. is method has proven to be a prom-
ising omic approach to diagnose metabolism changes in response to physiological stresses induced by pathol-
ogy24 or xenobiotic exposure25. Regarding gastrointestinal or inammatory disorders, Ahmed et al. reported
that changes in fecal VOC pattern may result from changes in the microbiota and/or pathologies in the GIT26,27.
Recently, a previous work from Defois et al. showed in vitro that volatolomics along with metatranscriptomics
enable to decipher a rapid change in the gut microbiota activity following acute exposure to B[a]P while the gut
microbiota composition remained stable16.
In the present work, we characterized within in vitro systems the impact of six POPs and/or foodborne chem-
icals that are frequently found in the diet and considered them as models for the eects of various classes of
pollutants on human gut microbiota functions at the metatranscriptome and volatolome levels. We also meas-
ured the inammatory properties of the metabolites arising from this xenobiotic-gut microbiota interaction to
characterize their eects on gut homeostasis.
Pollutant exposure alters the fecal microbiota volatolome pattern. Analysis of the microbial vol-
atolome is a promising approach to detect an imbalance of microbial activity. Five pollutants (TCDD, deltame-
thrin, HBCD, B[a]P and PhIP) and one mixture of pollutants (PAHs) were screened for their impact on human
fecal microbiota functions following a 24-hr exposure. Briey, the pollutants were added at dierent concen-
trations into Hungate tubes along with a fecal microbiota suspension containing human in vitro-cultured feces.
Volatolome patterns were assessed by solid-phase microextraction coupled to gas chromatography-mass spec-
trometry (SPME-GC-MS) analysis and vehicle 1 and 2 conditions (methanol and methanol:dichloromethane
mixture, respectively) were conducted to remove the eects of the vehicles on the microbial community.
More than 250 volatile organic compounds (VOCs) were detected by SPME-GC-MS following the 24 hr of
pollutant exposure. We identied 5, 2, 7 and 4 VOCs that were signicantly altered by deltamethrin, PhIP, TCDD
and PAHs compared to their respective vehicle condition (Table1). Sulfur compounds (including thioesters)
were increased in samples exposed to deltamethrin and TCDD conditions with 3 and 5 compounds, respectively.
One ketone (2,2,4,4-tetramethyl-3-pentanone) decreased in deltamethrin, PhIP and TCDD conditions and one
hydrocarbon (m- or p-xylene) decreased in deltamethrin and PhIP conditions. Following PAHs exposure, one
phenol (4-methylphenol), one ester (propylphenylacetate) and one ketone (methylacetophenone) increased while
one unknown compound decreased. Finally no signicantly altered compounds were found following B[a]P and
HBCD exposure.
Pollutant exposure alters the fecal microbiota metatranscriptome. The volatolome analysis
showed that four tested chemicals (deltamethrin, PhIP, TCDD and PAHs) signicantly shied the microbial vola-
tile pattern, suggesting that the activity of the microbiota might have been aected. us, using RNA-sequencing,
we investigated the microbial response to chemicals by analyzing the dierential metatranscriptome between
exposed and non-exposed microbiota and then deducing the metabolic pathways that may have been altered.
Functional assignation was realized at the gene ontology (GO) slim term and at the gene family levels, and the
results are presented as copies per million units (CPM) abundances. To discard the eects of both vehicles on the
fecal microbiota, the pollutant samples were directly compared to the corresponding vehicle samples. Following
the 24 hr of exposure, variations observed at the GO level clustered the pollutant samples into two main groups
(Fig.1). e PAH, B[a]P and deltamethrin samples showed a strong downregulation of GO slim terms together
with a weak upregulation of slim terms, whereas the PhIP, TCDD and HBCD samples showed a strong upreg-
ulation of GO slim terms together with a weak downregulation of slim terms. Although each pollutant induced
specic transcriptomic responses, general trends were largely shared by the six pollutant samples, such as an
increase in transcript levels related to the lipid metabolism process, plasma membrane, periplasmic space, protein
kinase activity and receptor activity. Conversely, a decrease in transcript levels related to ribosome, translation
and nucleic acid binding was observed (Fig.2).
At the gene family level, the number and mean abundance of the dierentially expressed genes (>3-fold
change) diered among the pollutant samples (Fig.3). e number of upregulated genes varies from 157 to 456
for the B[a]P and PAH exposure, respectively. e number of downregulated genes varied from 174 to 245 for
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
the PhIP and PAH exposure, respectively (Fig.3A). While the mean abundance of upregulated genes was within
a similar range for all samples (from 29 CPM for the B[a]P to 43 for the HBCD samples), the mean abundance
of downregulated genes was far higher for the PAH sample (from 7 CPM for the deltamethrin to 63 for the PAH
samples) (Fig.3B). e high mean abundance of downregulated genes in the PAH sample might explain the sub-
stantial downregulation observed for some GO slim terms (Fig.1).
Among the dierentially expressed genes, we identied three rubredoxin (Rdx)-coding genes that were found
in the most upregulated genes in the PhIP and PAH samples compared with their respective vehicle samples (27
to 437-fold change) (Supplementary Data1). e products of this gene family have been implicated in the alkane
degradation pathway, which is part of hydrocarbon metabolism28,29.
Some genes were found to be specically induced by the pollutants (not expressed in their respective vehicle
condition) and will be referred as “pollutant-specic genes” (Supplementary Data2). PhIP and PAHs shared the
Figure 1. Transcript levels related to microbial GO slim terms that were up and downregulated aer the 24 hr
of pollutant exposure. Analysis was performed on the pooled rRNA-depleted RNA arising from ve technical
replicates. Variations are expressed as the Z-Score. Lines represent GO slim terms, columns represent pollutant
Volatile Metabolite m/zaLRIbIDc
p-valuedRatio (Pollutant / Vehicle)
Sulfur compounds
Carbon disulde 76 <600 a,b 7.4E-04 3.80
Dimethyl disulde 94 748 a,b 2.3E-03 1.8E-03 1.69 2.14
Dimethyl trisulde 126 983 a,b 2.5E-03 5.5E-05 1.78 2.39
4- or 5-methyl-2-acetylthiazole 126 1116 a,b 2.3E-03 1.51
Dimethyl tetrasulde 79 1243 a,b 1.0E-03 9.6E-04 3.68 6.21
S-methyl 3-methylbutanethioate 85 945 a 2.3E-03 1.46
4-methylphenol 105 1076 a,b 3.0E-04 1.30
Propylphenylacetate 91 1345 a,b 3.0E-03 2.86
2,2,4,4-tetramethyl-3-pentanone 85 939 a,b 4.0E-06 0.0E + 00 2.0E-06 0.52 0.56 0.53
Methylacetophenone 119 1198 a,b 2.2E-04 1.61
m- or p-xylene 91 875 a,b 4.0E-04 2.1E-04 0.38 0.38
Unknown 57 <600 8.3E-04 0.37
Tot ale5 2 7 4
Table 1. Volatile metabolites detected in the fecal microbiota volatolome as signicantly altered by the
pollutants. DeltaM: deltamethrin. aMass fragment used for peak area determination. bLinear retention index on
a RTX-5MS capillary column. cTentative identication based on (a) mass spectrum, (b) linear retention index
from the literature. dP-values corrected for multiple testing. eTotal number of volatiles signicantly altered by
the pollutants.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
largest number of pollutant-specic genes (41 genes), highlighting common microbial metabolic pathways acti-
vated by the exposure (Fig.4A). Conversely, the PAH sample shared few pollutant-specic genes (7 to 11 genes)
with the other chemicals (except with PhIP). We identied 109 to 1 pollutant-specic genes shared by 2 to 6 of the
chemicals, respectively (Fig.4B and Supplementary Data2). Among the pollutant-specic genes, a Rdx-coding
gene (dierent from the three others previously described) was the most highly induced gene by the HBCD (344
CPM). Finally, a gene that was specically induced by the PhIP and PAH pollutants encodes an uncharacterized
protein harboring the Toluene_X Outer Membrane Transport family domain (UniRef50_R5K1C5). Proteins of
this family are involved in toluene catabolism and the degradation of aromatic hydrocarbons. One gene that was
specically expressed in response to the 6 pollutants was found to be an uncharacterized protein-coding gene
(UniRef50_R7EHV5) (Supplementary Data2).
Fermentation-derived supernatants do not induce TC7 cell death. As shown above, pollutant expo-
sure modied the microbial activity and thus modied the compounds produced in the fermentation-derived
supernatants (FDS). We can assume that the microbial community may also metabolize the pollutants and con-
vert them into more or less harmful compounds towards the host. ese compounds may induce cell damage in
the intestinal epithelium, potentially through the release of inammatory molecules.
To test these hypotheses, we exposed TC7 cells to FDS for 4 hr. Cells were analyzed by ow cytometry to
assess their viability, and the cell culture supernatant was harvested to quantify pro (IL-8, TNFα) and anti (IL-
10) inammatory cytokine release. No dierences in the proportion of necrotic or apoptotic cells were observed
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Figure 2. Transcript levels related to microbial GO slim terms that were up and downregulated aer the 24 hr
of pollutant exposure. Variations are expressed as the log2 of the pollutant and the vehicle CPM abundance ratio
(y-axis). Analysis was performed on the pooled rRNA-depleted RNA arising from ve technical replicates. GO
slim terms are represented on the x-axis. GO: gene ontology.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
between the pollutant and vehicle samples. Only exposure to 10% DMSO, a necrotic and apoptotic reagent used
as positive control, led to a signicant increase in both necrotic and apoptotic cells, making up 25.7% and 7.9%
of the total cells, respectively (Supplementary Figure1). FDS was also compared to fecal microbiota-free colon
medium supplemented with each pollutant at its initial experimental concentration. Without the fecal microbi-
ota, a slight increase in necrotic (and apoptotic for PAHs) cells was observed for the PhIP, B[a]P and PAH samples
(Fig.5). Necrotic cells increased from 0.72, 0.72 and 0.76% to 1.40, 1.31 and 1.49% in the PhIP, B[a]P and PAH
samples, respectively. Apoptotic cells in the PAH sample increased from 0.64 to 1.14%.
Fermentation-derived supernatants alter IL-8 production in TC7 cells. IL-8, TNFα and IL-10
release was measured in TC7 cell supernatants to highlight a putative pro- or anti-inammatory cell response.
e vehicle samples did not induce the release of IL-8 compared with DMEM (Fig.6). However, the control
condition induced a slight signicant increase in IL-8 compared with the vehicle 1 condition (62.1 to 101.5 ng/mL).
e deltamethrin, HBCD and PAH samples showed induction of a signicant increase in IL-8 compared with
their associated vehicle sample. e strongest increase was observed for the PAH sample, which exhibited a
3.85-fold increase (from 62.1 to 239 ng/mL). e responses to PAHs and the IL-1β (pro-inammatory control)
were similar, with 239 and 298 ng/mL of IL-8 release. Compared with the microbiota-free conditions, signicant
variations were observed for the deltamethrin and PAH samples, with, on average, a 2-fold increase. Interestingly,
the PhIP and B[a]P samples showed induction of less IL-8 release compared with the microbiota-free condition,
but these variations were not signicant. In contrast to IL-8, TNFα and IL-10 were not detected in any of the
culture cell supernatants.
Food pollution by chemicals is of great concern due to the toxicity of the compounds that accumulate in the food
chain and because the exposure occurs chronically throughout life. While the toxicity toward the host has been
evaluated for some representatives of the main groups of contaminants, their impact on the gut microbiota has
received less attention. In this work, we investigated the impact of six pollutants on human gut microbiota activity
at the volatolome and metatranscriptome levels. e microbial- and chemical-derived compounds generated
0100 200300 400500 600700 80
Number of genes
upregulated genesdownregulated genes
upregulated genesdownregulated genes
Number of genes
Figure 3. Dierentially expressed microbial genes aer the 24 hr of pollutant exposure. (A) Number of
dierentially expressed genes. (B) Mean abundances in CPM of the dierentially expressed genes. Analysis was
performed on the pooled rRNA-depleted RNA arising from ve technical replicates. Only genes with at least
a 3-fold change are represented, and values were derived from a comparison between the pollutant and the
vehicle condition.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
during acute (24 hr) exposure of the microbiota to the pollutants were then assessed in TC7 cell monolayers to
characterize their toxicity and inammatory properties in the host.
e doses used in this work are lower or in the range of previous studies carried out to examine the impact
of TCDD, PhIP and B[a]P on the gut microbiota, allowing us to make comparisons and generate discus-
sions13,14,16,21,22. e doses used for PAH, HBCD and deltamethrin exposures were far lower than those used for
toxicity studies in mice3032. e doses used in this study are still higher than the expected daily consumption.
However, the purpose of this study was to investigate a unique exposure to pollutants that might provide initial
insights into their eects on the human gut microbiota. Of course, further studies will be necessary to mimic the
chronic exposure that occurs throughout a person’s life.
e study of the physiology of the GIT and the role of the gut microbiota is dicult in humans due to ethical
(e.g. exposure to pathogens, chemicals, pharmaceuticals) and technical (diculty to access the GIT) aspects,
most oen limiting studies to fecal analysis (non-invasive, cheap). Our work was based on in vitro systems thus
allowing us to decipher the direct impact of the pollutants on the gut microbiota. Such systems have been used
Pollutant specific response Pollutant shared response
1 2 3 4 5 6
TCDD HBCD Deltamethrin B[a]P PhIP PAHs
31 28 24 24 8 TCDD
39 30 33 8 HBCD
29 27 11 Deltamethrin
19 7 B[a]P
41 PhIP
Figure 4. Microbial genes specically induced by pollutants aer the 24 hr of exposure. (A) Number of
pollutant-specic genes shared between each couple of pollutants. (B) Representation of the core pollutant-
specic genes. Analysis was performed on the pooled rRNA-depleted RNA arising from ve technical replicates.
% of cells
necrosis apoptosis
* * *
Figure 5. Percentage of necrotic and apoptotic TC7 cells aer 4 hr of FDS and microbiota-free medium
exposure. Values are the mean of the three replicates ± SEM. Signicant variations were assessed using the
Mann-Whitney test (p-value < 0.05). mf: microbiota-free.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
in various applications such as the fermentation of food components3335, the impact of antibiotics on the micro-
biota of patients with Crohn’s disease36, the metabolism of gut methanogenic archaea37 or the degradation of
toxic compounds such as PAHs by the gut microbial metabolism21. Meanwhile these models are missing the host
counterpart, thus the results arising from this work should be considered carefully until in vivo experiments are
VOCs are small molecules produced by living organisms that play an important role in chemical ecology,
specically in the biological interactions between organisms38. During the past decade, VOCs have gained rec-
ognition in the health care eld because they are presently used as biomarkers to detect various human diseases,
including cancers39,40. In this work, we analyzed the volatolome pattern of the fecal microbiota aer 24 hr of pol-
lutant exposure. Overall, a partially shared response between deltamethrin and TCDD exposure was observed,
with an enrichment of the microbial volatolome with sulfur compounds and a decrease in one ketone compound
(2,2,4,4-tetramethyl-3-pentanone) while following PhIP and PAHs exposure the volatolome patterns appeared
more specic (Table1). Surprisingly we observed no signicant shi in the VOC pattern following HBCD and
B[a]P exposure contrary to a previous work in which two human fecal microbiota were exposed to B[a]P at three
gradual concentrations16. More precisely, in the rst study, at the same concentration that was used in the present
work, a decrease in 1 ketone and 1 ester compound was observed. However, while not signicant (p-value< 0.05
but >0.05/ni), similar variations have been highlighted in the present work following B[a]P exposure including
the decrease of 1 ketone and 9 ester compounds (data not shown). Until now, studies examining microbial VOCs
have been scarce, and only a few available databases have described VOCs, their emitting organisms and their
biological activities41,42. Despite limited information on VOC biological activities, some links between microbial
VOC patterns and many physiological and pathological states have been reported, including gastrointestinal met-
abolic disorders43,44. A decrease in volatolome ketones has recently been reported in patients with an inamed gut
(Crohns disease, ulcerative colitis or pouchitis)44. Moreover, patients with Crohn’s disease showed increased pro-
duction of phenol, as observed herein following PAHs exposure. However, sulfur compounds, which increased
in this study, decreased in patients with Crohns disease. As alterations in the microbial VOC patterns are a con-
sequence of the disruption of the normal bacterial ecology in pathologies such as inammatory bowel disease
(IBD), it can be hypothesized that similar disturbances (shi in VOC proles) are triggered by chemical agents,
such as environmental pollutants.
To obtain a more detailed characterization of the altered metabolic pathways, we analyzed gut microbiota gene
expression using RNA sequencing. e variations observed at the GO level were pollutant-dependent; however,
general trends emerge from the analysis, showing an increase in transcript levels related to the lipid metabolism
process, plasma membrane and periplasmic space following dioxin, brominated ame retardant and heterocyclic
amine exposure. A previous study from the laboratory also identied an increase in these metabolic pathways
aer a 24-hr B[a]P exposure16, indicating a clear impact of such hydrophobic compounds on cell membranes. It
has been proposed that lipophilic compounds, when crossing membranes, increase the membrane uidity, lead-
ing to a loss of membrane functionality45. One of the major adaptive mechanisms of bacteria cells to counteract
this eect is to increase their membrane rigidity (enhance membrane lipid saturation) to prevent compound
accumulation within the cell46.
We also identied an increase in transcript levels related to protein kinase activity and receptor activity mainly
for TCDD, HBCD and deltamethrin exposure. Such variations have never been identied elsewhere following
environmental toxicant exposures. However, the increase in the transcript levels of these two GO slim terms
might indicate an increase in the cell signaling network and thus an activation or repression of cellular responses
due to the presence of the pollutants.
Il-8 concentraon (pg/mL)
Figure 6. IL-8 release in the TC7 cell culture supernatants. TC7 cells were exposed to FDS and microbiota-free
medium for 4 hr. Values represent the mean of three replicates ± SEM. Signicant variations were assessed using
the Mann-Whitney test (p-value < 0.05). DMEM was a negative control for toxicity and inammation, whereas
IL-1β was a positive control for inammation in TC7 cells. Control: no pollutant and no vehicle; Vehicle 1:
methanol; Vehicle 2: methanol:dichloromethane 1:1; mf: microbiota-free.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
A decrease in transcript levels related to the GO slim terms ribosome, translation and nucleic acid binding
was observed. In a recent study, we identied a reduction in energy metabolism following B[a]P exposure and
proposed that the bacterial cells might engage adaptive processes to manage stressful events. Microorganisms
may thus engage energy for adaptation mechanisms to ensure necessary physiological functions prior to energy
expenditure for growth46. Ribosome assembly and protein synthesis processes are major targets for a large num-
ber of antibiotics47. is observation potentially raises the hypothesis that POPs may act as antibiotics target-
ing the bacterial translation apparatus. Interestingly, a > 2-fold increase in 13 antimicrobial resistance genes
was observed in the murine gut microbiome within 8 days of TCDD exposure14. Among these genes, some
(multidrug-resistant genes) were associated with resistance to antibiotics targeting bacterial protein synthesis
(aminoglycoside, glycylcycline, macrolide and erythromycin).
Rubredoxin-coding genes have been found to be highly induced in PhIP and PAH samples and found specif-
ically (absence of the vehicle condition) in the HBCD sample. Rdxs are essential electron transfer components of
bacterial membrane-bound alkane hydroxylases found in aerobic n-alkane degradation pathways28,48. However,
in anaerobic organisms, Rdxs have been identied as crucial for oxidative stress responses (reduction of oxygen
or reactive oxygen species)49.
Interestingly, a gene encoding an unknown protein carrying a Toluene_X Outer Membrane Transport family
domain was identied as specic to the PhIP and PAH samples. is protein domain is found in membrane pro-
teins with an uncharacterized function that are involved in toluene catabolism and the degradation of aromatic
hydrocarbons50,51. Hence, our result highlights the potential metabolism of PhIP and PAH compounds by the
human gut microbiota. is result is in agreement with previous studies showing that the gut microbiota is capa-
ble of metabolizing these chemical compounds into 1-hydroxypyrene, 7-hydroxybenzo[a]pyrene and PhIP-M1
as pyrene, benzo[a]pyrene and PhIP metabolites, respectively2123.
Gut microbial fermentation products play a major role in human health and disease52. An imbalance of these
compounds (mediated by altered microbial activity) may directly or indirectly impact the gut environment and
the host. However, although the microbial metabolism of xenobiotics, such as POPs, has been demonstrated,
the toxicity of their metabolites remains unknown. us, we investigated the impact of FDS on the TC7 cell
line by measuring the induction of the necrotic and apoptotic processes, along with the release of inammatory
cytokines aer 4 hr of contact.
e FDS did not specically induce necrosis or apoptosis in the TC7 cell line under these experimental con-
ditions. Moreover, the microbiota seemed to limit the necrotic eect of PhIP, B[a]P and PAHs. us, the gut
microbiota could play a protective role for the host against some toxic compounds. At this stage, it is not possi-
ble to precisely identify the protective mechanism and discriminate between a potential pollutant degradation
or sequestration by the microbiota. No necrotic or apoptotic eects have been observed for the other pollut-
ants under our experimental conditions. We cannot exclude toxic eects aer prolonged contact periods and/
or with other cell lines. Concerning the inammatory response, FDS from deltamethrin, HBCD and PAH sam-
ples induced a signicant increase in IL-8 production by TC7 cells. Our assumption is that pollutants induce a
functional dysbiosis that modies the balance between anti-inammatory and pro-inammatory metabolites in
the supernatant. By contrast, we also observed that the microbiota that were in contact with pollutants, such as
PhIP and B[a]P, could slightly reduce the release of IL-8. In this case, the microbiota could also play a protective
role against inammatory induction by chemical compounds, but as mentioned previously, we could not deter-
mine the involved mechanisms (pollutant degradation and/or sequestration, production of anti-inammatory
metabolites). However, it must be considered that previous in vivo studies showed the establishment of a
pro-inammatory intestinal environment following chronic B[a]P exposure at high doses53,54. B[a]P has also
been shown to potentiate murine intestinal inammation caused by a high-fat diet55.
TNFα and IL-10 cytokines were not detected in any of the culture cell supernatants. ese two cytokines have
been previously detected in Caco-2 experiments; however, immune cells56,57 and/or bacterial cells58,59 seem to be
obligate partners to induce their expression and release. Other experimental conditions, such as cellular dier-
entiation and incubation time, must be taken into account because the cytokine expression varies depending on
these parameters. As an example, the general inammatory response is higher in proliferating cells compared
with fully dierentiated cells60,61.
Chronic pollutant expositions may progressively induce a low-grade inammatory status. To our knowl-
edge, no data are available regarding the inammatory properties induced by POPs in intestinal epithelial cells.
However, environmental chemicals have been characterized as triggering a pro-inammatory response mediated
by the aryl hydrocarbon receptor (AhR) in dierent cell types6264. e AhR is a cytosolic transcription factor
that is activated by numerous environmental hydrophobic chemicals, leading to their metabolic clearance and
detoxication. While the AhR is oen regarded as a xenobiotic receptor, it is becoming increasingly clear that this
receptor exhibits activity that inuences numerous endogenous functions, including immune functions65,66. For
example, Kobayashi and colleagues have shown that environmental exposure to TCDD, through binding to AhR,
exacerbates rheumatoid arthritis pathophysiology via stimulation of the NF-κB and ERK signaling pathways67.
e rodent AhR homolog is known to bind TCDD and PAHs with ~10-fold higher anity than the human
AhR68. ese results highlight the functional disparities that may exist in rodent model systems, resulting in a
failure to accurately predict human AhR function in response to given ligands.
Finally, intestinal epithelial cells are simultaneously exposed to (i) gut microbiota-derived compounds, (ii) gut
microbiota metabolites generated by the presence of the chemicals and (iii) the pollutant along with its poten-
tial degradation compound(s). is result indicates that pollutant exposure risks, based primarily on human
biotransformation enzymes, may also take into account gut microbial processes, leading to more or less toxic
compounds and/or microbial pro-inammatory molecules. Depending on the pollutant and the intensity and fre-
quency of exposure, gut microbiota could either protect host cells or enhance toxic and inammatory responses.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
e present work highlights, for the rst time, the impact of a panel of POPs and foodborne chemical fam-
ilies on human gut microbiota functions. We identified microbial volatiles and metabolic pathways that
shied aer chemical exposure, leading to an imbalance in microbial activity. Finally, we showed that this gut
microbiota-pollutant interplay might potentially lead to the establishment of a pro-inammatory state in the gut.
erefore, chemical exposure risk assessment based primarily on human biotransformation enzymes might be
Materials and Methods
Chemicals. Deltamethrin (pyrethroid insecticide), α-hexabromocyclododecane (α-HBCD), γ-hexabromo-
cyclododecane (γ-HBCD) (BFRs), B[a]P (PAH), PAH Mix 3, methanol and dichloromethane were purchased
from Sigma Aldrich (Saint-Quentin Fallavier, France). TCDD (PCDD) and PhIP (HCA) were purchased from
LGC Standards (Molsheim, France). To avoid solubility issues in batches, all pollutants were dissolved in meth-
anol (vehicle 1) except PAH Mix 3, which was purchased already dissolved in a methanol:dichloromethane (1:1)
(v/v) solution (vehicle 2). e HBCD solution was an equal mixture of the α and γ isomers. e composition
of the PAH Mix 3 solution is detailed in Supplementary Table1. Chemicals and all contaminated euents and
materials were handled in an advised and safe manner with all necessary precautions.
Experimental design. e pollutants were added at dierent concentrations (see below) into Hungate tubes
along with a fecal microbiota suspension sampled from the continuous fermentor Mini Bioreactor Applikon®
(Applikon, e Netherlands) following seven days of microbial stabilization. e fecal microbiota suspension
contained in vitro-cultured feces collected from a human volunteer donor. Informed consent was obtained from
the healthy volunteer. is was a non-interventional study with no additions to usual clinical care. According to
French Health Public Law (CSP Art L 1121-1.1), such a protocol does not require approval of an ethics commit-
tee. e incubation volume (10 mL) was composed of one-fourth fecal microbiota suspension and three-fourths
colon medium as previously described16.
e pollutant concentrations in batches were 0.005, 0.90, 2.60, 5, 21 and 38 µg/mL for TCDD, PhIP, HBCD,
B[a]P, deltamethrin, and PAHs, respectively. Vehicle 1 and vehicle 2 were added at 0.5% (v/v) in batches. e
concentration of methanol was kept below 1% (v/v) in medium to avoid potential microbial growth inhibition69.
To take into account the impact of the vehicles on the fecal microbiota, batches with only vehicle 1 or 2 (vehicle 1
condition and vehicle 2 condition) at 0.5% (v/v) and batches with no pollutant and no vehicle (control condition)
were added to the experimental design. Five replicates were assessed for all control and experimental conditions.
At the end (T24 hr) of the incubation step, samples dedicated to RNA extractions were immediately cen-
trifuged at 2000 × g for 8 min. e pellets were then resuspended in 5 volumes of RNAlater® (Fisher Scientic,
Illkirch, France) and maintained at 80 °C until extraction. e remaining incubation medium was either directly
maintained at 20 °C for SPME-GC-MS analysis or centrifuged at 2000 × g for 10 min (referred as FDS). e ve
FDS replicates were pooled and maintained at 20 °C until used to challenge TC7 cells.
Microbial volatolome analysis. e volatolome analysis was performed as previously described by Defois
et al.16. Briey, the volatile compounds in the samples were analyzed via SPME-GC-MS. A volatile compound
analysis was performed by GC-full scan MS (GC6890, MS5973N, Agilent). e volatiles were tentatively identi-
ed according to a comparison between their mass spectra and the NIST 14 mass spectral library and between
published retention index (RI) values and the RI values of an internal databank. Peak areas of the volatile com-
pounds were determined with a home-made automatic algorithm developed in Matlab R2014b (e MathWorks,
Natick, USA). e data were processed using Statistica soware (v.10) (StatSo, Maisons-Alfort, France). T-tests
(p < 0.05) were applied to datasets corresponding to each case-control study (exposed group vs vehicle group). In
order to limit the risk of false positive results, the p-values of compounds selected by t-tests were then corrected
for multiple testing: aer the pre-selection of the ni responding compounds (p < 0.05), a Bonferroni correction
(p < 0.05/ni) was applied for each of the 6 case-control comparisons.
RNA extraction, sequencing and analysis. RNA extraction and rRNA depletion were performed as pre-
viously described16. e metatranscriptome analysis was performed on the pooled rRNA-depleted RNA arising
from ve technical replicates.
Library construction (following TruSeq Stranded mRNA Sample Preparation, Illumina) and paired-end
sequencing (MiSeq, 2 × 250 bp) were performed at Fasteris (Plan-les-Ouates, Switzerland). e paired-end
sequences were assessed for quality with Trimmomatic70 and PRINSEQ71. and joined with fastq-join from the
ea-utils soware package72. e remaining rRNA sequences were removed from the data set using SortMeRNA
(v. 2.0) soware73. e UniRef50 gene family and GO slim term relative abundances in CPM were obtained using
the HMP Unied Metabolic Analysis Network2 (HUMAnN2) soware (v0.5)74. GO slim term-derived heatmaps
were created using Shinyheatmap soware75. Only genes with at least a 3-fold change between the pollutant and
the vehicle conditions were analyzed.
TC7 cell culture. TC7 cells (clone of the parenteral Caco-2 epithelial cell line) were kindly provided by Dr.
Adeline Sivignon (M2iSH, Clermont-Ferrand, France). Caco-2 and TC7 cell lines are popularly used for studies
on intestinal metabolism and absorption of various pharmaceutical and nutritional compounds76,77. TC7 cell
line is a Caco-2 clone thus presenting numerous properties found in enterocytes such as cell polarization, brush
border, cell junctions as well as cell metabolism enzymes. However, clone TC7 shows better homogeneity than the
parental Caco line as well as more developed intercellular junctions. Also, the TC7 line has a faster metabolism
than the Caco line leading to a complete dierentiation of the cells under 14 days of culture compared to 21 days
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
as required by the Caco line61. e cell culture medium consisted of Dulbecco’s Modied Eagle Medium with
high glucose (4.5 g/L) supplemented with 10% fetal bovine serum, 1% glutamine, 1% non-essential amino acids
(100X) and 1% penicillin-streptomycin (100X). DMEM and the added components were purchased from Gibco®
(Fisher Scientic).
TC7 cells were maintained in 75-cm² asks (Falcon, Fisher Scientic) at 37 °C in a humidied atmosphere
of 5% CO2. When the cells reached 80% conuence, the medium was removed from the dish, and cells were
washed twice with 10 mL of PBS solution (Gibco, Fisher Scientic). e cells were then supplemented with 0.25%
trypsin-EDTA (Gibco, Fisher Scientic) and le in the incubator for 5 min. Trypsin action was stopped by addi-
tion of 10 mL of complete medium, and the cell suspension was centrifuged for 5 min at 900 g. Aer removing the
supernatant, the cell pellet was resuspended in complete medium, seeded directly into 12-well plates Nunclon
(Fisher Scientic) (2.105 cells/well) and maintained in culture for 14 days to allow complete cell dierentiation
before challenge61. e medium was changed three times a week beginning at the rst week and every other day
until day 14. TC7 cells were used between passages 30 and 41.
Exposure of TC7 cells to fermentation-derived supernatants. Cells were treated for 4 hr with the
FDS from each pollutant, vehicle and control conditions. Furthermore, TC7 cells were also exposed to fecal
microbiota-free colon medium supplemented with each pollutant at its initial experimental concentration
(microbiota-free condition). e supernatants were diluted 1:4 in DMEM because this dilution of the colon
medium showed no cytotoxic eect on TC7 cells (results not shown). Finally, cellular control conditions (DMEM,
dimethyl sulfoxide (DMSO) 10% (Eurobio, Les Ulis, France) and Interleukin (IL) 1 beta (IL-1β) (Sigma Aldrich)
at 25 ng/mL) were included in the experimental design, and each condition was assessed in triplicate. DMSO
and IL-1β were used as positive controls for the induction of toxicity (apoptosis and necrosis) and inammation
(cytokine release) in TC7 cells, respectively.
Following a 4-hr of exposure, the cellular supernatants were stored at 80 °C for cytokine release measure-
ments, and the cell monolayers were harvested for apoptosis/necrosis detection. e results are the mean of three
replicates, and statistical analyses were conducted using the Mann-Whitney U-test with GraphPad Prism 5 so-
ware (San Diego, CA, USA). e statistical signicance was set at p < 0.05.
Apoptosis detection. TC7 cell monolayers were washed twice with Dulbecco’s Phosphate-Buffered
Saline (Gibco, Fisher Scientific) and treated with trypsin-EDTA 0.25%. Cells were recovered with cold
Phosphate-Buffered Saline (Gibco, Fisher Scientific), centrifuged (500 g, 4 °C, 5 min) and subjected to the
Annexin A5-FITC Kit (Beckman Coulter, Villepinte, France) following the manufacturer’s instructions. e
assay combines Annexin A5 and Propidium Iodide staining, distinguishing viable cells from apoptotic cells and
necrotic cells, respectively. Cells were then analyzed with a Cytomics FC 500 MPL ow cytometer.
TC7 cytokine quantication. TC7 cell supernatants were centrifuged (1,000 g, 4 °C, 12 min), and the
amount of released IL-8, Tumor Necrosis Factor alpha (TNFα) and IL-10 was determined using the Human IL-8
/ CXCL8 ELISA Kit, Human TNF-Alpha ELISA Kit and Human IL-10 ELISA Kit (Sigma Aldrich), respectively.
Cytokine concentrations were assessed according to the manufacturer’s instructions.
Accession codes. All sequence data produced via RNA sequencing are available in the NCBI Sequence Read
Archive, BioProject PRJNA416988, under accession no. SRP124200.
1. Jones, . C. & de Voogt, P. Persistent Organic Pollutants (POPs): State of the Science. Environ. Pollut. 100, 209–221 (1999).
2. uiz, P., Perlina, A., Mumtaz, M. & Fowler, B. A. A Systems Biology Approach eveals Converging Molecular Mechanisms that Lin
Dierent POPs to Common Metabolic Diseases. Environ. Health Perspect. 124, 1034–1041 (2016).
3. inoshita, H. et al. Breadown of Mucosal Immunity in Gut by 2,3,7,8-Tetraclorodibenzo-p-dioxin (TCDD). Environ. Heal. Prev.
Med. 11, 256–263 (2006).
4. Liamin, M. et al. Benzo[a]pyrene-induced DNA damage associated with mutagenesis in primary human activated T lymphocytes.
Biochem. Pharmacol. 137, 113–124 (2017).
5. Yang, P. et al. Urinary metabolites of polycyclic aromatic hydrocarbons, sperm DNA damage and spermatozoa apoptosis. J. Hazard.
Mater. 329, 241–248 (2017).
6. Shen, J. et al. Dependence of cancer ris from environmental exposures on underlying genetic susceptibility: an illustration with
polycyclic aromatic hydrocarbons and breast cancer. Br. J. Cancer 116, 1229–1233 (2017).
7. Wei, Y. et al. Benzo[a]pyrene promotes gastric cancer cell proliferation and metastasis liely through the Aryl hydrocarbon receptor
and E-dependent induction of MMP9 and c-myc. Int. J. Oncol. 49, 2055–2063 (2016).
8. WHO & IAC. Some Naturally occuring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC
Monographs on the Evaluation of Carcinogenic Risks to Humans 56, (1993).
9. Bouvard, V. et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 16, 1599–600 (2015).
10. Jin, Y., Wu, S., Zeng, Z. & Fu, Z. Eects of environmental pollutants on gut microbiota. Environ. Pollut. 222, 1–9 (2017).
11. oca-Saavedra, P. et al. Food additives, contaminants and other minor components: eects on human gut microbiota-a review. J.
Physiol. Biochem. 1–15 (2017).
12. Zhang, L. et al. Persistent Organic Pollutants Modify Gut Microbiota – Host Metabolic Homeostasis in Mice Through Aryl
Hydrocarbon eceptor Activation. Environ. Health Perspect. 123, 679–688 (2015).
13. Lefever, D. E. et al. TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-
induced hyperglycemic mice. Toxicol. Appl. Pharmacol. 304, 48–58 (2016).
14. Stedtfeld, . D. et al. TCDD inuences reservoir of antibiotic resistance genes in murine gut microbiome. FEMS Microbiol. Ecol. 93,
1–8 (2017).
15. Choi, J. J. et al. Exercise Attenuates PCB-Induced Changes in the Mouse Gut. Microbiome. 121, 725–730 (2013).
16. Defois, C. et al. Environmental Pollutant Benzo[a]Pyrene Impacts the Volatile Metabolome and Transcriptome of the Human Gut
Microbiota. Front. Microbiol. 8, 1562 (2017).
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
17. Claus, S. P., Guillou, H. & Ellero-Simatos, S. e gut microbiota: a major player in the toxicity of environmental pollutants? Nat.
Publ. Gr. Biolms Microbiomes 2, 16003 (2016).
18. Spanogiannopoulos, P., Bess, E. N., Carmody, . N. & Turnbaugh, P. J. e microbial pharmacists within us: a metagenomic view of
xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273–287 (2016).
19. Maurice, C. F., Haiser, H. J. & Turnbaugh, P. J. Xenobiotics shape the physiology and gene expression of the active human gut
microbiome. Cell 152, 39–50 (2013).
20. Mendel, J. L. & Walton, M. S. Conversion of p,p’-DDT to p,p’-DDD by Intestinal Flora of the at. Science. 151, 1527–1528 (1966).
21. Van de Wiele, T. et al . Human Colon Microbiota Transform Polycyclic Aromatic Hydrocarbons to Estrogenic Metabolites. Environ.
Health Perspect. 113, 6–10 (2005).
22. Vanhaece, L. et al. Metabolism of the Food-Associated Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by Human
Intestinal Microbiota. J. Agric. Food Chem. 54, 3454–3461 (2006).
23. Fery, M. I. et al. e strict anaerobic gut microbe Eubacterium hallii transforms the carcinogenic dietary heterocyclic amine
2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP). Environ. Microbiol. Rep. 8, 201–209 (2016).
24. Haim, M. et al. Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways. Chem. Rev. 112, 5949–5966
25. Berge, P. et al. Use of volatile compound metabolic signatures in poultry liver to bac-trace dietary exposure to rapidly metabolized
xenobiotics. Environ. Sci. Technol. 45, 6584–6591 (2011).
26. Ahmed, I., Greenwood, ., Costello, B. D. L., atclie, N. M. & Probert, C. S. An Investigation of Fecal Volatile Organic Metabolites
in Irritable Bowel Syndrome. PLoS One 8, 1–13 (2013).
27. Ahmed, I., Greenwood, ., Costello, B., atclie, N. & Probert, C. S. Investigation of faecal volatile organic metabolites as novel
diagnostic biomarers in inammatory bowel disease. Aliment. Pharmacol. er. 43, 596–611 (2016).
28. van Beilen, J. B. et al. ubredoxins Involved in Alane Oxidation. J. Bacteriol. 184, 1722–1732 (2002).
29. Shanlin, J. & Whittle, E. Evidence lining the Pseudomonas oleovorans alane g-hydroxylase, an integral membrane diiron
enzyme, and the fatty acid desaturase family. FEBS Lett. 545, 188–192 (2003).
30. B en Slima, A. et al. Endocrine disrupting potential and reproductive dysfunction in male mice exposed to deltamethrin. Hum. Exp.
Toxicol. 36, 218–226 (2017).
31. Long, A. S., Lemieux, C. L., Gagné, ., Lambert, I. B. & White, P. A. Genetic Toxicity of Complex Mixtures of Polycyclic Aromatic
Hydrocarbons: Evaluating Dose-Additivity in a Transgenic Mouse Model. Environ. Sci. Technol. 51, 8138–8148 (2017).
32. Szabo, D. T., Pathmasiri, W., Sumner, S. & Birnbaum, L. S. Serum Metabolomic Proles in Neonatal Mice following Oral Brominated
Flame etardant Exposures to HBCD Alpha, Gamma and Commercial Mixture. Environ. Health Perspect. 125, 651–659 (2017).
33. Lesmes, U., Beards, E. J., Gibson, G. ., Tuohy, . M. & Shimoni, E. Eects of resistant starch type III polymorphs on human colon
microbiota and short chain fatty acids in human gut models. J. Agric. Food Chem. 56, 5415–5421 (2008).
34. Pompei, A. et al. In v itro comparison of the prebiotic eects of two inulin-type fructans. Anaerobe 14, 280–286 (2008).
35. Taagi, . et al. A single-batch fermentation system to simulate human colonic microbiota for high-throughput evaluation of
prebiotics. PLoS One 11, e0160533 (2016).
36. Maccaferri, S. et al. ifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a
continuous culture colonic model system. J. Antimicrob. Chemother. 65, 2556–2565 (2010).
37. Tottey, W. et al. In-vitro model for studying methanogens in human gut microbiota. Anaerobe 34, 50–52 (2015).
38. Schenel, D., Lemfac, M. C., Piechulla, B. & Splivallo, . A meta-analysis approach for assessing the diversity and specicity of
belowground root and microbial volatiles. Front. Plant Sci. 6, 707 (2015).
39. Arasaradnam, . P., Covington, J. A., Harmston, C. & Nwoolo, C. U. eview article: Next generation diagnostic modalities in
gastroenterology - Gas phase volatile compound biomarer detection. Aliment. Pharmacol. er. 39, 780–789 (2014).
40. Agarwal, S. M. & Sharma, M. & Fatima, S. VOCC: a database of volatile organic compounds in cancer. RSC Adv. 6, 114783–114789
41. Lemfac, M. C., Nicel, J., Dunel, M., Preissner, . & Piechulla, B. MVOC: A database of microbial volatiles. Nucleic Acids Res. 42,
744–748 (2014).
42. Abdullah, A. A. et al. Development and Mining of a Volatile Organic Compound Database. Biomed Res. Int. 2015, 139254 (2015).
43. Boots, A. W., Bos, L. D., van der Schee, M. P., van Schooten, F. J. & Ster, P. J. Exhaled Molecular Fingerprinting in Diagnosis and
Monitoring: Validating Volatile Promises. Trends Mol. Med. 21, 633–644 (2015).
44. De Preter, V. et al. Faecal metabolite proling identies medium-chain fatty acids as discriminating compounds in IBD. Gut 64,
447–458 (2015).
45. Siema, J., De Bont, J. A. M. & Poolman, B. Interactions of cyclic hydrocarbons with biological membranes. J. Biol. Chem. 269,
8022–8028 (1994).
46. Murínová, S. & Dercová, . esponse mechanisms of bacterial degraders to environmental contaminants on the level of cell walls
and cytoplasmic membrane. Int. J. Microbiol. 873081 (2014).
47. Wilson, D. N. ibosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Publ. Gr. 12, 35–48 (2014).
48. Nie, Y. et al. Diverse alane hydroxylase genes in microorganisms and environments. Sci. Rep. 4, 4968 (2014).
49. Hagelueen, G. et al. Crystal structure of the electron transfer complex rubredoxin–rubredoxin reductase of Pseudomonas
aeruginosa. PNAS 104, 12276–12281 (2007).
50. ahng, H., Byrne, A. M., Olsen, . H. & uor, J. J. Characterization and ole of tbuX in Utilization of Toluene by alstonia picettii
PO1. J. Bacteriol. 182, 1232–1242 (2000).
51. Wang, Y. et al. Identication of a membrane protein and a truncated Lys-type regulator associated with the toluene degradation
pathway in Pseudomonas putida F1. Mol. Gen. Genet. 246, 570–579 (1995).
52. Lee, W.-J. & Hase, . Gut microbiota-generated metabolites in animal health and disease. Nat. Chem. Biol. 10, 416–424 (2014).
53. ibière, C., Peyret, P., Parisot, N., Darcha, C. & Déchelotte, P. J. Oral exposure to environmental pollutant benzo[a]pyrene impacts
the intestinal epithelium and induces gut microbial shis in murine model. Sci. Rep. 6, 31027 (2016).
54. Ajayi, B. O., Adedara, I. A. & Farombi, E. O. Benzo(a)pyrene induces oxidative stress, pro-inammatory cytoines, expression of
nuclear factor-appa B and deregulation of wnt/beta-catenin signaling in colons of BALB/c mice. Food Chem. Toxicol. 95, 42–51
55. ha lil, A. et al. Polycyclic aromatic hydrocarbons potentiate high-fat diet eects on intestinal inammation. Toxicol. Lett. 196,
161–167 (2010).
56. Panja, A., Siden, E. & Mayer, L. Synthesis and regulation of accessory/proinammatory cytoines by intestinal epithelial cells. Clin.
Exp. Immunol. 100, 298–305 (1995).
57. Hyun, J. et al. Immunity Human Intestinal Epithelial Cells Express Interleuin-10 through Toll-Lie eceptor 4-Mediated Epithelial-
Macrophage Crosstal. J. Innate Immun. 7, 87–101 (2015).
58. Bahrami, B., Child, M. W., Macfarlane, S. & Macfarlane, G. T. Adherence and Cytoine Induction in Caco-2 Cells by Bacterial
Populations from a ree-Stage Continuous-Culture Model of the Large Intestine. Appl. Environ. Microbiol. 77, 2934–2942 (2011).
59. Parlesa, A., Haller, D., Brinz, S., Baeuerlein, A. & Bode, C. Modulation of Cytoine elease by Dierentiated CACO-2 Cells in a
Compartmentalized Coculture Model with Mononuclear Leucocytes and Nonpathogenic Bacteria. Scand. J. Immunol. 60, 477–485
Content courtesy of Springer Nature, terms of use apply. Rights reserved
SCIENtIFIC REPORTS | (2018) 8:11006 | DOI:10.1038/s41598-018-29376-9
60. Walle, V. D. et al. Y. Inflammatory parameters in Caco-2cells: Effect of stimuli nature, concentration, combination and cell
dierentiation. Toxicol. Vitr. 24, 1441–1449 (2010).
61. Zeller, P. et al. Multiparametric temporal analysis of the Caco-2/TC7 demonstrated functional and dierentiated monolayers as early
as 14 days of culture. Eur. J. Pharm. Sci. 72, 1–11 (2015).
62. Pei, X. et al. Polycyclic aromatic hydrocarbons induce Il-8 expression through nuclear factor b activation in A549 cell line. Cytokine
19, 236–241 (2002).
63. Tamai, A. et al. Polycyclic Aromatic Hydrocarbon Increases mNA Level for Interleuin 1 Beta in Human Fibroblast-Lie
Synoviocyte Line via Aryl Hydrocarbon eceptor. Biol. Pharm. Bull. 27, 407–410 (2004).
64. Henley, D. V., Bellone, C. J., Williams, D. A., uh, T. S. & uh, M. F. Aryl hydrocarbon receptor-mediated posttranscriptional
regulation of IL-1 b. Arch. Biochem. Biophys. 422, 42–51 (2004).
65. Schiering, C. et al. Feedbac control of AH signalling regulates intestinal immunity. Nature 542, 242–245 (2017).
66. Stocinger, B., Di Meglio, P., Gialitais, M. & Duarte, J. H. e Aryl Hydrocarbon eceptor: Multitasing in the Immune System.
Annu. Rev. Immunol. 32, 403–432 (2014).
67. obayashi, S. et al. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology 47,
1317–1322 (2008).
68. amadoss, P. & Perdew, G. H. Use of 2-Azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a Probe to Determine the elative
Ligand Anity of Human versus Mouse Aryl Hydrocarbon eceptor in Cultured Cells. Mol. Pharmacol. 66, 129–136 (2004).
69. Patterson, J. A. & ice, S. C. Eect of ethanol and methanol on growth of ruminal bacteria Selenomonas ruminantium and
Butyrivibrio brisolvens. J. Environ. Sci. Heal. 50, 62–67 (2015).
70. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a exible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120
71. Schmieder, . & Edwards, . Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863–864 (2011).
72. Aronesty, E. Comparison of Sequencing Utility Programs. Open Bioinforma. J. 7, 1–8 (2013).
73. opylova, E., Noe, L. & Touzet, H. SortMeNA: fast and accurate filtering of ribosomal NAs in metatranscriptomic data.
Bioinformatics 28, 3211–3217 (2012).
74. Abubucer, S. et al. Metabolic econstruction for Metagenomic Data and Its Application to the Human Microbiome. PLoS Comput.
Biol. 8, e1002358 (2012).
75. homtchou, B. B., Hennessy, J. . & Wahlestedt, C. Shinyheatmap: Ultra fast low memory heatmap web interface for big data
genomics. PLoS One 12, e0176334 (2017).
76. Turco, L. et al. Caco-2/TC7 cell line characterization for intestinal absorption: How reliable is this in vitro model for the prediction
of the oral dose fraction absorbed in human? Toxicol. Vitr. 25, 13–20 (2011).
77. Hu, M., Ling, J., Lin, H. & Chen, J. Use of Caco-2 cell monolayers to study drug absorption and metabolism. Methods Pharmacol.
Tox icol. 19–35 (2004).
CD received a graduate grant from the “Ministère de l’Enseignement Supérieur et de la Recherche” of France. We
thank Magaly Angénieux and Frédéric Mercier for providing technical assistance in the SPME-GC-MS analysis.
Author Contributions
C.D., P.P., P.M., G.G., J.R. and E.E. conceived the study and design the experiments. C.D. and J.R. performed
experimental procedures. C.D., J.R., E.E., and P.P. analyzed data. S.D. and O.L. provided support for continuous
fermentation and G.G. and J.T. for cell culture and cytometry experiments. C.D., P.P., J.R. and E.E. interpreted
data and wrote the manuscript. All authors reviewed and approved the manuscript. All authors agree to be
accountable for all aspects of the work.
Additional Information
Supplementary information accompanies this paper at
Competing Interests: e authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional aliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. e images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the
copyright holder. To view a copy of this license, visit
© e Author(s) 2018
Content courtesy of Springer Nature, terms of use apply. Rights reserved
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
... A growing number of studies have indicated that the composition and diversity of the host gut microbiota are readily affected by various types of environmental pollutants including food chemicals and pesticides, suggesting that the role of gut microbiota is getting more and more attention in the study of the pesticide toxicity to non-target organisms (Jin et al., 2017Defois et al., 2018). Yuan et al. (2019) concluded that the correlation between gut microbiota of mammals or zebrafish and health in relation to multiple effects of fungicides and result in physiological disorders of the host. ...
... However, gut dysbiosis disrupts the interdependence and may reduce the beneficial effects or even bring reverse effects. Conversely, the composition of gut microbiota can also be disrupted by many factors, such as food (Defois et al., 2018), pesticide (Jin et al., 2015(Jin et al., , 2017Zhang et al., 2019), and some environmental chemicals (Li et al., 2020). It is gradually agreed that gut microbiome is considered a major but underestimated factor in assessing the toxicity of environmental contaminants (Claus et al., 2016). ...
Fungicide thiram, a representative dithiocarbamate pesticide can cause potential health hazards to humans and animal health due to the residues in various agricultural products. However, the effects of thiram on lipid metabolism by perturbing gut microbiota of chickens are not clear. Our study was aimed to explore the protective of polysaccharide extracted from Morinda officinalis (MOP) on acute thiram-exposed chickens, and to analyze the association between alteration of gut microbiota and lipid metabolism. Three hundred chicks are fed with a normal diet, thiram-treated diet (100 mg/kg), and a thiram-treated diet supplemented with 250, 500, or 1000 mg/kg MOP was used in this study, respectively. The results showed that thiram exposure prominently elevated liver index, changed liver function by histopathological examination and serum biochemistry diagnoses, and increased blood lipid parameters. Meanwhile, the expression level of some key genes in hepatic lipid metabolism dysregulated significantly in the thiram-exposed chickens. Furthermore, 16S rRNA gene sequencing indicated that thiram exposure can significantly alter the richness, diversity, and composition of the broiler fecal micro-biota, and the relative abundance of Firmicutes and Proteobacteria was also affected at the phylum level. In addition, some microbial populations including Lactobacillus, Ruminococcus, Oscillospira, Blautia, and Butyr-icicoccus significantly decreased at the genus level, whereas the Klebsiella was opposite. Correlation analysis further revealed a significant association between microorganisms and lipid metabolism-related parameters. Optimistically, 500 mg/kg MOP can alleviate the damage of thiram in the gut and liver. Together, these data suggest that thiram exposure causes the imbalance of the gut microbiota and hepatic lipid metabolism disorder in chickens.
... The gut microbiota serves as a biological regulator and filter, detecting and altering a large number of chemical signals from the environment before they move throughout the body. Gut bacterial communities, by themselves, persist at the host-environment interface and can have a considerable impact on human health [Defois et al. 2018]. The complex network containing various biological mechanisms promoting bidirectional communication of the brain and the bacteria residing in the gut is termed 'gutmicrobiota-brain.' It is essential in sustaining the GI, CNS and microbial homeostasis systems of animals [Fung 2020]. ...
The human gut microbiome has received considerable attention since it has been demonstrated that it changes with obesity, diabetes, liver illnesses, cancer and neurological diseases and has been pointed out to be of key importance for the treatment of obesity-related and neurological diseases. Focusing on the neurodegenerative diseases, gut resident microbiota seems to interfere in normal brain functioning. Recent advancements in research shed light on the detailed physiology of the microbiome, its active role in disease and health, its relationship with stress and how modifications in the gut microbiota tend to influence behavioral changes. The dynamic nature of the microbiome stimulates the CNS signaling mechanism, which contributes to its active role in healthy homeostasis. This review aimed to highlight the role of microorganisms in the maintenance of normal homeostasis, their influence on mood disorders such as depression and anxiety, their potential implications in the management and treatment of depressive disorders.
... 30 In addition, recent works suggest that volatolomics may provide a promising alternative to more classical metabolomics platform to reveal significant changes in the metabolism of single culture 31 or microbiota. 32 Once integrated, this information provides an overview of microorganism associations and their metabolic and sense/response pathways within the food. 33 These approaches offer an additional advantage as they are nontargeted and they by-pass the culturing step that may not always recover the targeted microorganism from the food. ...
Full-text available
The EU-project SAFFI targets food for EU's 15 million and China's 45 million children under the age of three. It aims at developing an integrated approach to enhance the identification, assessment, detection and mitigation of health risks raised by microbial and chemical hazards along EU and China infant food chains. SAFFI will benchmark the main risks through an extensive hazard identification system based on multiple data sources and a risk ranking procedure. It will also develop procedures to enhance top-down and bottom-up hazard control by combining management options with a panel of technologies for the detection and mitigation of priority hazards. Furthermore, it will explore unexpected contaminants by predictive toxicology and improve risk-based food safety management of biohazards by omics and predictive microbiology. SAFFI will co-develop with and deliver to stakeholders a decision-support system (DSS) to enhance safety control all along the food chain. This DSS will integrate the databases, procedures and methods described above and will be a framework for a generic DSS dedicated to other food. This overall methodology will also be implemented in a complementary Chinese side of the project, and exemplified for each side, with four case studies that were selected to cover priority hazards, main ingredients, processes and control steps of the infant food chain. Resulting databases, tools and procedures will be shared, cross-validated, concatenated, benchmarked and finally harmonized for further use in the EU and China. This EU-China multi-actor consortium of 20 partners involves academia, food safety authorities, infant food companies, a paediatrics association and technological and data-science SMEs.
... In addition, contaminants in food or an excessive amount of artificial additives have a detrimental effect on human health and even cause various diseases. For instance, interference with the intestinal microbiota's metabolites caused by food contaminants (polycyclic aromatic hydrocarbons, polychlorobiphenyls, brominated flame retardants, dioxins, pesticides, and heterocyclic amines) may promote the establishment of an inflammatory state in the intestine [3]. Food emulsifiers and thickeners influence the intestinal microbiota, mucosal barriers, and inflammatory pathways, and there are numerous possible pathogenic mechanisms [4]. ...
Full-text available
In recent years, entity relation extraction has been a critical technique to help people analyze complex structured text data. However, there is no advanced research in food health and safety to help people analyze the complex concepts between food and human health and their relationships. This paper proposes an entity relation extraction method FHER for the few-shot learning in the food health and safety domain. For few-shot learning in the food health and safety domain, we propose three methods that effectively improve the performance of entity relationship extraction. The three methods are applied to the self-built data sets FH and MHD. The experimental results show that the method can effectively extract domain-related entities and their relations in a small sample size environment.
... Among the different microbiota, the most characterized is the gastro-intestinal one, which plays a main role as a dynamical interface between the host and the external exposome (7). Intestinal dysbiosis has been associated with marked structural changes in the mucosa, including permeability and inflammation. ...
Full-text available
There is a growing interest in the characterization of the involvement of toxicant and pollutant exposures in the development and the progression of several diseases such as obesity, diabetes, cancer, as well as in the disruption of the immune and reproductive homeostasis. The gut microbiota is considered a pivotal player against the toxic properties of chemicals with the establishment of a dynamic bidirectional relationship, underlining the toxicological significance of this mutual interplay. In fact, several environmental chemicals have been demonstrated to affect the composition, the biodiversity of the intestinal microbiota together with the underlining modulated metabolic pathways, which may play an important role in tailoring the microbiotype of an individual. In this review, we aimed to discuss the latest updates concerning the environmental chemicals–microbiota dual interaction, toward the identification of a distinctiveness of the gut microbial community, which, in turn, may allow to adopt personalized preventive strategies to improve risk assessment for more susceptible workers.
... One possible reason is that cooking meat at high temperature forms foodborne carcinogens/mutagens, such as heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) that can directly trigger cancerous changes in colonic epithelium [4]. In addition, Defois et al. demonstrated that foodborne chemicals, including HCAs and PAHs, disrupt gut microbiota metabolism, which promotes IL-8 release by intestinal epithelial cells to generate a pro-inflammatory state [5], a critical component of intestinal tumorigenesis [6]. In fact, growing evidence shows that microbiota dysbiosis is associated with the development of colorectal cancer. ...
The bidirectional interaction between carcinogens and gut microbiota that contributes to colorectal cancer is complicated. Reactivation of carcinogen metabolites by microbial β-glucuronidase (βG) in the gut potentially plays an important role in colorectal carcinogenesis. We assessed the chemoprotective effects and associated changes in gut microbiota induced by pre-administration of bacterial-specific βG inhibitor TCH-3511 in carcinogen azoxymethane (AOM)-treated APCMin/+ mice. AOM induced intestinal βG activity, which was reflected in increases in the incidence, formation, and number of tumors in the intestine. Notably, inhibition of gut microbial βG by TCH-3511 significantly reduced AOM-induced intestinal βG activity, decreased the number of polyps in both the small and large intestine to a frequency that was similar in mice without AOM exposure. AOM also led to lower diversity and altered composition in the gut microbiota with a significant increase in mucin-degrading Akkermansia genus. Conversely, mice treated with TCH-3511 and AOM exhibited a more similar gut microbiota structure as mice without AOM administration. Importantly, TCH-3511 treatment significant decreased Akkermansia genus and produced a concomitant increase in short-chain fatty acid butyrate-producing gut commensal microbes Lachnoospiraceae NK4A136 group genus in AOM-treated mice. Taken together, our results reveal a key role of gut microbial βG in promoting AOM-induced gut microbial dysbiosis and intestinal tumorigenesis, indicating the chemoprotective benefit of gut microbial βG inhibition against carcinogens via maintaining the gut microbiota balance and preventing cancer-associated gut microbial dysbiosis. Thus, the bacterial-specific βG inhibitor TCH-3511 is a potential chemoprevention agent for colorectal cancer.
... Lastly, as mentioned for upper gut models, to further investigate host-microbiome crosstalk, canine in vitro models should be coupled to cell culture assays, as previously described for human models (Bahrami et al., 2011;Chassaing et al., 2017;Geirnaert et al., 2017;Defois et al., 2018). Zelst et al., 2015;Lee et al., 2017) or phytoconstituents like polyphenols. ...
Full-text available
Dogs occupy a full place in the family and their well-being is of paramount importance to their owners. Digestion, a complex process involving physicochemical, mechanical, and microbial parameters, plays a central in maintaining animals healthy. As in vivo studies in dogs are more and more restricted by ethical, regulatory, societal, and cost reasons, an alternative option resides in the use of in vitro models simulating the different parts of the canine gastrointestinal tract. This review paper first introduces digestion and gut microbiota as key factors in dog nutrition and health, under both healthy and diseased conditions (obesity and inflammatory bowel disease), by highlighting when relevant similarities or differences between human and canine digestion process. Then, we provide for the first time an in-depth description of currently available models of the canine digestive tract, discuss technical and scientific challenges that need to be addressed and introduce potential applications of in vitro gut models in food and veterinary fields. Even if the development of some in vitro models remains limited by a lack of in vivo data in dogs necessary for a relevant configuration and validation, translation of long-term expertise on human in vitro gut models to dog's ecosystem opens avenues for canine in vitro gut model development and their adaptation to specific digestive conditions associated to various ages, sizes, breeds and/or diets, under both physiological and diseased states.
Chemically intensive crop production depletes wildlife food resources, hinders animal development, health, survival, and reproduction, and it suppresses wildlife immune systems, facilitating emergence of infectious diseases with excessive mortality rates. Gut microbiota is crucial for wildlife's response to environmental stressors. Its composition and functionality are sensitive to diet changes and environmental pollution associated with modern crop production. In this study we use shotgun metagenomics (median 8,326,092 sequences/sample) to demonstrate that exposure to modern crop production detrimentally affects cecal microbiota of sharp-tailed grouse (Tympanuchus phasianellus: 9 exposed, 18 unexposed and greater prairie chickens (T. cupido; 11, 11). Exposure to crop production had greater effect on microbiota richness (t = 6.675, P < 0.001) and composition (PERMANOVA r² = 0.212, P = 0.001) than did the host species (t = 4.762, P < 0.001; r² = 0.070, P = 0.001) or their interaction (t = 3.449; r² = 0.072, both P = 0.001), whereas sex and age had no effect. Although microbiota richness was greater in exposed (T. cupido chao1 = 152.8 ± 20.5; T. phasianellus 115.3 ± 17.1) than in unexposed (102.9 ± 15.1 and 101.1 ± 17.2, respectively) birds, some beneficial bacteria dropped out of exposed birds' microbiota or declined and were replaced by potential pathogens. Exposed birds also had higher richness and load of virulome (mean ± standard deviation; T. cupido 24.8 ± 10.0 and 10.1 ± 5.5, respectively; T. phasianellus 13.4 ± 6.8/4.9 ± 2.8) and resistome (T. cupido 46.8 ± 11.7/28.9 ± 10.2, T. phasianellus 38.3 ± 16.7/18.9 ± 14.2) than unexposed birds (T. cupido virulome: 14.2 ± 13.5, 4.5 ± 4.2; T. cupido resistome: 31.6 ± 20.2 and 13.1 ± 12.0; T. phasianellus virulome: 5.2 ± 4.7 and 1.4 ± 1.5; T. phasianellus resistome: 13.7 ± 16.1 and 4.0 ± 6.4).
Microbial safety of infant food is a priority for food producers, regulatory authorities and consumers. Infant food is destined to a particularly sensitive section of the population that is more susceptible to foodborne diseases if compared to the general population. Preventive approaches are applied during production and commercialization that rely on the principles of Hazard Analysis Critical Control Points and on Good Hygiene Practices to guarantee food safety. Nevertheless, microbial safety hazards in infant foods still pose a public health risk. With the purpose of better understanding why and how pathogenic microorganisms contaminate infant food, an approach that integrates omics methods is here proposed and reviewed. Omics approaches are employed to study the microbial ecology of foods, to investigate the interactions of microorganisms within an ecosystem and to delineate the behavior of microorganisms during food processing.
Full-text available
Benzo[a]pyrene (B[a]P) is a ubiquitous, persistent, and carcinogenic pollutant that belongs to the large family of polycyclic aromatic hydrocarbons. Population exposure primarily occurs via contaminated food products, which introduces the pollutant to the digestive tract. Although the metabolism of B[a]P by host cells is well known, its impacts on the human gut microbiota, which plays a key role in health and disease, remain unexplored. We performed an in vitro assay using 16S barcoding, metatranscriptomics and volatile metabolomics to study the impact of B[a]P on two distinct human fecal microbiota. B[a]P exposure did not induce a significant change in the microbial structure; however, it altered the microbial volatolome in a dose-dependent manner. The transcript levels related to several metabolic pathways, such as vitamin and cofactor metabolism, cell wall compound metabolism, DNA repair and replication systems, and aromatic compound metabolism, were upregulated, whereas the transcript levels related to the glycolysis-gluconeogenesis pathway and bacterial chemotaxis toward simple carbohydrates were downregulated. These primary findings show that food pollutants, such as B[a]P, alter human gut microbiota activity. The observed shift in the volatolome demonstrates that B[a]P induces a specific deviation in the microbial metabolism.
Full-text available
Exposure to environmental chemicals has been linked to various health disorders, including obesity, type 2 diabetes, cancer and dysregulation of the immune and reproductive systems, whereas the gastrointestinal microbiota critically contributes to a variety of host metabolic and immune functions. We aimed to evaluate the bidirectional relationship between gut bacteria and environmental pollutants and to assess the toxicological relevance of the bacteria–xenobiotic interplay for the host. We examined studies using isolated bacteria, faecal or caecal suspensions—germ-free or antibiotic-treated animals—as well as animals reassociated with a microbiota exposed to environmental chemicals. The literature indicates that gut microbes have an extensive capacity to metabolise environmental chemicals that can be classified in five core enzymatic families (azoreductases, nitroreductases, β-glucuronidases, sulfatases and β-lyases) unequivocally involved in the metabolism of >30 environmental contaminants. There is clear evidence that bacteria-dependent metabolism of pollutants modulates the toxicity for the host. Conversely, environmental contaminants from various chemical families have been shown to alter the composition and/or the metabolic activity of the gastrointestinal bacteria, which may be an important factor contributing to shape an individual’s microbiotype. The physiological consequences of these alterations have not been studied in details but pollutant-induced alterations of the gut bacteria are likely to contribute to their toxicity. In conclusion, there is a body of evidence suggesting that gut microbiota are a major, yet underestimated element that must be considered to fully evaluate the toxicity of environmental contaminants.
Full-text available
Background Transcriptomics, metabolomics, metagenomics, and other various next-generation sequencing (-omics) fields are known for their production of large datasets, especially across single-cell sequencing studies. Visualizing such big data has posed technical challenges in biology, both in terms of available computational resources as well as programming acumen. Since heatmaps are used to depict high-dimensional numerical data as a colored grid of cells, efficiency and speed have often proven to be critical considerations in the process of successfully converting data into graphics. For example, rendering interactive heatmaps from large input datasets (e.g., 100k+ rows) has been computationally infeasible on both desktop computers and web browsers. In addition to memory requirements, programming skills and knowledge have frequently been barriers-to-entry for creating highly customizable heatmaps. Results We propose shinyheatmap: an advanced user-friendly heatmap software suite capable of efficiently creating highly customizable static and interactive biological heatmaps in a web browser. shinyheatmap is a low memory footprint program, making it particularly well-suited for the interactive visualization of extremely large datasets that cannot typically be computed in-memory due to size restrictions. Also, shinyheatmap features a built-in high performance web plug-in, fastheatmap, for rapidly plotting interactive heatmaps of datasets as large as 10⁵—10⁷ rows within seconds, effectively shattering previous performance benchmarks of heatmap rendering speed. Conclusions shinyheatmap is hosted online as a freely available web server with an intuitive graphical user interface: The methods are implemented in R, and are available as part of the shinyheatmap project at: Users can access fastheatmap directly from within the shinyheatmap web interface, and all source code has been made publicly available on Github:
Full-text available
Gut bacteria play an important role in several metabolic processes and human diseases, such as obesity and accompanying co-morbidities, such as fatty liver disease, insulin resistance/diabetes, and cardiovascular events. Among other factors, dietary patterns, probiotics, prebiotics, synbiotics, antibiotics, and non-dietary factors, such as stress, age, exercise, and climatic conditions, can dramatically impact the human gut microbiota equilibrium and diversity. However, the effect of minor food constituents, including food additives and trace contaminants, on human gut microbiota has received less attention. Consequently, the present review aimed to provide an objective perspective of the current knowledge regarding the impacts of minor food constituents on human gut microbiota and consequently, on human health.
Full-text available
Background: Most studies of environmental risk factors and breast cancer are conducted using average risk cohorts. Methods: We examined the association between polycyclic aromatic hydrocarbon (PAH)-albumin adducts in bloods from baseline and breast cancer risk in a prospective nested case-control study (New York site of the BCFR, 80 cases and 156 controls). We estimated the 10-year absolute breast cancer risk by a risk model that uses pedigree information (BOADICEA) and evaluated whether the increased risk from PAH differed by absolute risk. Results: Women with detectable levels of PAH had a twofold association with breast cancer risk (odds ratio (OR)=2.04; 95% CI=1.06-3.93) relative to women with non-detectable levels. The association increased with higher levels of PAH (?median) and by a higher level of absolute breast cancer risk (10-year risk ?3.4%: OR=4.09, 95% CI=1.38-12.13). Conclusions: These results support that family-based cohorts can be an efficient way to examine gene-environment interactions.British Journal of Cancer advance online publication, 28 March 2017; doi:10.1038/bjc.2017.81
Full-text available
The aryl hydrocarbon receptor (AHR) recognizes xenobiotics as well as natural compounds such as tryptophan metabolites, dietary components and microbiota-derived factors, and it is important for maintenance of homeostasis at mucosal surfaces. AHR activation induces cytochrome P4501 (CYP1) enzymes, which oxygenate AHR ligands, leading to their metabolic clearance and detoxification. Thus, CYP1 enzymes have an important feedback role that curtails the duration of AHR signalling, but it remains unclear whether they also regulate AHR ligand availability in vivo. Here we show that dysregulated expression of Cyp1a1 in mice depletes the reservoir of natural AHR ligands, generating a quasi AHR-deficient state. Constitutive expression of Cyp1a1 throughout the body or restricted specifically to intestinal epithelial cells resulted in loss of AHR-dependent type 3 innate lymphoid cells and T helper 17 cells and increased susceptibility to enteric infection. The deleterious effects of excessive AHR ligand degradation on intestinal immune functions could be counter-balanced by increasing the intake of AHR ligands in the diet. Thus, our data indicate that intestinal epithelial cells serve as gatekeepers for the supply of AHR ligands to the host and emphasize the importance of feedback control in modulating AHR pathway activation.
This study evaluates the risk assessment approach currently employed for polycyclic aromatic hydrocarbon (PAH)-contaminated media, wherein carcinogenic hazards are evaluated using a dose-addition model that employs potency equivalency factors (PEFs) for targeted carcinogenic PAHs. Here, Muta™Mouse mice were sub-chronically exposed to PAH mixtures (p.o.), and mutagenic potency (MP) values were determined for five tissues. Predicted dose-additive mixture MPs were generated by summing the products of the concentrations and MPs of the individual targeted PAHs; values were compared to the experimental MPs of the mixtures to evaluate dose-additivity. Additionally, the PEF-determined BaP-equivalent concentrations were compared to those determined using a bioassay-derived method (BDM) (i.e., an additivity-independent approach). In bone marrow, mixture mutagenicity was less than dose-additive and the PEF-method provided higher estimates of BaP-equivalents than the BDM. Conversely, mixture mutagenicity in site-of-contact tissues (e.g., small intestine) was generally more than dose-additive and the PEF-method provided lower estimates of BaP-equivalents than the BDM. Overall, this study demonstrates that dose-additive predictions of mixture mutagenic potency based on the concentrations and potencies of a small number of targeted PAHs results in values that are surprisingly close to those determined experimentally, providing support for the dose-additive assumption employed for human health risk assessment of PAH mixtures.
Dysbiosis of the gut microbiome via antibiotics, changes in diet, and infection can select for bacterial groups that more frequently harbor antimicrobial resistance genes (ARGs) and mobile genetic elements (MGEs). However, the impact of environmental toxicants on the reservoir of ARGs in the gut microbiome has received less attention. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent aryl hydrocarbon receptor (AhR) agonist with multiple toxic health effects including immune dysfunction. The selective pressure of TCDD on the abundance of ARG and MGE harboring gut populations was examined using C57BL/6 mice exposed to 0-30 μg/kg TCDD for 28 and 92 days with the latter having a 30-day recovery period. DNA extracted from temporally collected fecal pellets was characterized using a qPCR array with 384 assays targeting ARGs and MGEs. Fourteen genes, typically observed in Enterobacteriaceae, increased significantly within eight days of initial dosing, persisted throughout the treatment period, and remained induced 30 days post dosing. A qPCR primer set targeting Enterobacteriaceae also showed 10- to 100-fold higher abundance in TCDD treated groups, which was further verified using metagenomics. Results show a bloom of ARG harboring bacterial groups in the gut due to a xenobiotic compound that is not a metal, biocide, or antimicrobial.
Inconsistent results between polycyclic aromatic hydrocarbons (PAHs) exposure and adverse male reproductive health have been reported in humans. To assess whether PAH exposure is associated with declined sperm function. Ten monohydroxylated PAHs (OH-PAHs) metabolites were analyzed in repeated urine samples from an infertility clinic. We used multivariable linear models to estimate the associations of urinary OH-PAH metabolites with sperm DNA damage (n = 405) and spermatozoa apoptosis (n = 366). The shapes of dose-dependent associations of exposure measurements with outcomes were further evaluated by restricted cubic splines. Multiple comparisons were adjusted by false discovery rate (FDR). We found that urinary 9-hydroxyfluorene (9-OHFlu) was associated with increased tail length and comet length (p for trend = 0.05 and 0.01, respectively), and that urinary 9-hydroxyphenanthrene (9-OHPh) was associated with decreased percentage of Annexin V⁻/PI⁻ spermatozoa (p for trend = 0.04). Also, suggestive associations of urinary 9-OHPh and ∑OHFlu with increased comet length, and urinary 9-OHFlu and 2-OHPh with decreased percentage of Annexin V⁻/PI⁻ spermatozoa were observed (all p for trends < 0.10). Further, these dose-dependent associations were confirmed in restricted cubic splines. Our results suggest that environmental exposure to fluorene and phenanthrene are associated with declined sperm function.